240 related articles for article (PubMed ID: 23377313)
1. GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis.
Li C; Long J; Hu X; Zhou Y
Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):859-68. PubMed ID: 23377313
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of cytochrome P450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patients.
Wang T; Yu HT; Wang W; Pan YY; He LX; Wang ZY
J Int Med Res; 2010; 38(3):977-86. PubMed ID: 20819434
[TBL] [Abstract][Full Text] [Related]
3. GSTM1 and GSTT1 null polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
Tang N; Deng R; Wang Y; Lin M; Li H; Qiu Y; Hong M; Zhou G
Int J Tuberc Lung Dis; 2013 Jan; 17(1):17-25. PubMed ID: 23232001
[TBL] [Abstract][Full Text] [Related]
4. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
Tang SW; Lv XZ; Zhang Y; Wu SS; Yang ZR; Xia YY; Tu DH; Deng PY; Ma Y; Chen DF; Zhan SY
J Clin Pharm Ther; 2012 Oct; 37(5):588-93. PubMed ID: 22335459
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury.
Feng FM; Guo M; Chen Y; Li SM; Zhang P; Sun SF; Zhang GS
Genet Mol Res; 2014 Nov; 13(4):9463-71. PubMed ID: 25501156
[TBL] [Abstract][Full Text] [Related]
6. GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs.
Chatterjee S; Lyle N; Mandal A; Kundu S
J Clin Pharm Ther; 2010 Aug; 35(4):465-70. PubMed ID: 20853551
[TBL] [Abstract][Full Text] [Related]
7.
Jaramillo-Valverde L; Levano KS; Tarazona DD; Vasquez-Dominguez A; Toledo-Nauto A; Capristano S; Sanchez C; Tarazona-Santos E; Ugarte-Gil C; Guio H
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232322
[TBL] [Abstract][Full Text] [Related]
8. The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.
Monteiro TP; El-Jaick KB; Jeovanio-Silva AL; Brasil PE; Costa MJ; Rolla VC; de Castro L
J Clin Pharm Ther; 2012 Dec; 37(6):712-8. PubMed ID: 22845549
[TBL] [Abstract][Full Text] [Related]
9. Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.
Singh HO; Lata S; Angadi M; Bapat S; Pawar J; Nema V; Ghate MV; Sahay S; Gangakhedkar RR
Pharmacogenomics J; 2017 Jan; 17(1):53-60. PubMed ID: 26667829
[TBL] [Abstract][Full Text] [Related]
10. Association of glutathione S-transferase polymorphisms (GSTM1 and GSTT1) with primary open-angle glaucoma: an evidence-based meta-analysis.
Huang W; Wang W; Zhou M; Chen S; Zhang X
Gene; 2013 Sep; 526(2):80-6. PubMed ID: 23747403
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.
Cai Y; Yi J; Zhou C; Shen X
PLoS One; 2012; 7(10):e47769. PubMed ID: 23082213
[TBL] [Abstract][Full Text] [Related]
12. Are genetic variations in glutathione S-transferases involved in anti-tuberculosis drug-induced liver injury? A meta-analysis.
Zhang M; Wu SQ; He JQ
J Clin Pharm Ther; 2019 Dec; 44(6):844-857. PubMed ID: 31378997
[TBL] [Abstract][Full Text] [Related]
13. GSTM1 and GSTT1 Gene Polymorphisms, Gene-Gene Interaction, and Esophageal Carcinoma Risk: Evidence from an Updated Meta-Analysis.
Ma L; Lan B; Guo L; Nong S; Huang C; Wu Q; Huang Z
Genet Test Mol Biomarkers; 2018 Jan; 22(1):11-19. PubMed ID: 29215312
[TBL] [Abstract][Full Text] [Related]
14. Null genotypes of GSTM1 and GSTT1 contribute to increased risk of diabetes mellitus: a meta-analysis.
Zhang J; Liu H; Yan H; Huang G; Wang B
Gene; 2013 Apr; 518(2):405-11. PubMed ID: 23296061
[TBL] [Abstract][Full Text] [Related]
15. Are glutathione S-transferase polymorphisms (GSTM1, GSTT1) associated with primary open angle glaucoma? A meta-analysis.
Lu Y; Shi Y; Yin J; Huang Z
Gene; 2013 Sep; 527(1):311-5. PubMed ID: 23827458
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic polymorphisms of
Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
[TBL] [Abstract][Full Text] [Related]
17. GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.
Yu C; Hequn C; Longfei L; Long W; Zhi C; Feng Z; Jinbo C; Chao L; Xiongbing Z
Oncotarget; 2017 Jan; 8(2):3246-3258. PubMed ID: 27911277
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) and endometriosis risk: a meta-analysis.
Ding B; Sun W; Han S; Cai Y; Ren M
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():114-20. PubMed ID: 25461363
[TBL] [Abstract][Full Text] [Related]
19. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
Sun F; Chen Y; Xiang Y; Zhan S
Int J Tuberc Lung Dis; 2008 Sep; 12(9):994-1002. PubMed ID: 18713495
[TBL] [Abstract][Full Text] [Related]
20. Association of GSTT1 and GSTM1 polymorphisms with early pregnancy loss in an Indian population and a meta-analysis.
Nair RR; Khanna A; Singh K
Reprod Biomed Online; 2013 Apr; 26(4):313-22. PubMed ID: 23433732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
